Literature DB >> 21877071

[Epidemiology of viral hepatitis in Mexico].

Arturo Panduro1, Griselda Escobedo Meléndez, Nora A Fierro, Bertha Ruiz Madrigal, Eloy Alfonso Zepeda-Carrillo, Sonia Román.   

Abstract

The main etiology of liver disease in Mexico is alcohol and viral hepatitis. The aim of the present study was to analyze the current epidemiology of viral hepatitis in Mexico. From 2000 to 2007 the Ministry of Health reported 192 588 cases of hepatitis, 79% HAV, 3.3% HBV, 6% HCV, and 12% without a specific etiologic factor. Due to high endemic areas for HBV infection in native Mexican population, limitations in the diagnostic sensitivity and specificity of the serological immunoassays used to date and presence of occult hepatitis B in the country, the real prevalence of HBV infection could be even higher than HCV in Mexico. Hepatitis E virus in cirrhotic patients and in porcine farms could at least partially explain the cases of hepatitis that are diagnosed without a specific etiologic agent. Specific strategies to establish control regulations against viral hepatitis infections in Mexico are proposed.

Entities:  

Mesh:

Year:  2011        PMID: 21877071

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  18 in total

Review 1.  HBV endemicity in Mexico is associated with HBV genotypes H and G.

Authors:  Sonia Roman; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 2.  Hepatitis E virus: An ancient hidden enemy in Latin America.

Authors:  Nora A Fierro; Mauricio Realpe; Tzintli Meraz-Medina; Sonia Roman; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

3.  Hepatitis B surface antibodies in medical students from a public university in Puebla, Mexico.

Authors:  María Elena Cárdenas-Perea; Eduardo Gómez-Conde; Gerardo Santos-López; Irma Pérez-Contreras; María Alicia Díaz-Orea; José Luís Gándara-Ramírez; Othón Rafael Cruz Y López; Luis Márquez-Domínguez; Francisca Sosa-Jurado
Journal:  Hum Vaccin Immunother       Date:  2016-05-12       Impact factor: 3.452

4.  Viral Kinetics of an Acute Hepatitis B Virus Subgenotype F1b Infection in a Mexican Subject.

Authors:  Arturo Panduro; Sonia Roman; Nora A Fierro; João R Rebello-Pinho
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-03-10

5.  CD36 genetic variation, fat intake and liver fibrosis in chronic hepatitis C virus infection.

Authors:  Omar Ramos-Lopez; Sonia Roman; Erika Martinez-Lopez; Nora A Fierro; Karina Gonzalez-Aldaco; Alexis Jose-Abrego; Arturo Panduro
Journal:  World J Hepatol       Date:  2016-09-08

Review 6.  Immunologic, metabolic and genetic factors in hepatitis C virus infection.

Authors:  Nora A Fierro; Karina Gonzalez-Aldaco; Rafael Torres-Valadez; Erika Martinez-Lopez; Sonia Roman; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

Review 7.  Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico.

Authors:  Omar Ramos-Lopez; Erika Martinez-Lopez; Sonia Roman; Nora A Fierro; Arturo Panduro
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

8.  T-helper 17-related cytokines and IgE antibodies during hepatitis A virus infection in children.

Authors:  Jorge L Trujillo-Ochoa; Karla F Corral-Jara; Griselda Escobedo-Meléndez; Mauricio Realpe; Arturo Panduro; Sonia Roman; Nora A Fierro
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-03-31       Impact factor: 2.743

Review 9.  Occult HBV infection: a faceless enemy in liver cancer development.

Authors:  Jaime Morales-Romero; Gustavo Vargas; Rebeca García-Román
Journal:  Viruses       Date:  2014-04-08       Impact factor: 5.048

10.  High prevalence of occult hepatitis B virus genotype H infection among children with clinical hepatitis in west Mexico.

Authors:  Griselda Escobedo-Melendez; Arturo Panduro; Nora A Fierro; Sonia Roman
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-08-05       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.